Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psilocybin-Assisted Therapy for Intergenerational Trauma
Sponsor: Rachel Yehuda
Summary
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
Official title: Processing Intergenerational Trauma With Psilocybin-Assisted Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-08-28
Completion Date
2030-01-02
Last Updated
2025-09-08
Healthy Volunteers
No
Conditions
Interventions
Psilocybin
Psilocybin 25mg, capsules taken orally under the supervision of two trained study therapists
Integration sessions
weekly integration sessions (therapy) for 6 weeks
Locations (1)
The Parsons Research Center for Psychedelic Healing
New York, New York, United States